A-443654 inhibits the phosphorylation of Akt with anti-inflammatory properties. It targets Akt1, Akt2, Akt3, CDK2, Chk1, CK2, cKIT, ERK2, Flt1, and GSK3β.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.